News
November 3-5, 2025
Event
Patrick Tremblay (COO) et Jean-Philippe Bürckert (CTO) will attend Bio-Europe in Vienna, Austria
September 17, 2025
Announcement
Dr. Elizabeth Quackenbush appointed Chief Medical Officer
September 2, 2025
Article
Ability produces an article about logic-gated engagers for precision biotherapeutics available in the most recent issue of Biopharma Dealmakers (published by Nature)
August 4, 2025
Announcement
Leadership team promotion announcement by Ability Biotherapeutics
June 18, 2025
Article
Engineering Smarter Antibodies: A Global Team Anchoring the Future of Immunotherapy in Montreal
June 3, 2025
Press Release
Ability Biotherapeutics Welcomes Angèle Maki, PhD to its Board of Directors
April 22, 2025
Press Release
Life sciences in Montréal: Jadco Group announces that its scientific hub, Inspire Bio Innovations, will be home to the next-generation targeted therapeutics company Ability Biotherapeutics
October 16, 2024
Press Release
Mila Partners with Ability Biologics to Advance AI Innovations in Antibody Discovery
June 18, 2024
Press Release
Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators
December 6, 2023
Press Release